Clearmind Medicine Inc. (CMND) reporting calendar
Clearmind Medicine Inc. files periodic reports with the SEC as CMND on Nasdaq. Atlas tracks 4 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Oct 2025
- Filed
- 20 Jan 2026
- Reports on record
- 4
Open CMND market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Oct 2025 | 20 Jan 2026 | 81 days | 0001213900-26-005665 |
| 20-F | 31 Oct 2024 | 22 Jan 2025 | 83 days | 0001213900-25-005490 |
| 20-F | 31 Oct 2023 | 29 Jan 2024 | 90 days | 0001213900-24-007413 |
| 20-F | 31 Oct 2022 | 6 Feb 2023 | 98 days | 0001213900-23-008056 |
Source: SEC EDGAR company submissions for CIK 0001892500. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.